Hanging On To A Research Grant For Decades: What's The Secret?

Wisconsin geneticist Oliver Nelson: "Stick with the real problems. Stay flexible and learn new techniques." Scan the lists of grants awarded by the National Institutes of Health or the National Science Foundation and you'll find that there are several hundred scientists who seem to have the knack of finding a funding source and keeping it -- not for the one or two renewals that most scientists consider the answer to a prayer, but for two or three decades. How do they manage this? Scientists w

Written byScott Huler
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

Scientists whose research has earned them decades-long stretches of government funding deny that there is anything special about their work -- and some funding agency officials agree.

"I'm not sure there's a formula except doing good science," says Anne Dieffenbach of the Office of Research Reports at NIH's National Institute of General Medical Sciences.

Nonetheless, says Bruce Umminger, division director of the NSF division of integrative biology and neuroscience, "I think there are certain characteristics these scientists share."

Indeed, the scientists interviewed for this article have certain traits in common that, while not a guarantee of 40 consecutive years of support, can function almost as a how-to list for doing good science. And good science often leads to consistent funding. The key to steady funding does not necessarily lie in the practical applicability of one's research results. "The research that has come from my lab," says Oscar Ratnoff, a professor ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies